YN
Yigal Nochomovitz
#666 out of 1960 analysts
Citigroup
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
2.84%
Gain -0.28%
Monthly
-1.01%
Yearly
-11.49%
Drawdown
76.26%
$41,176.65
Equity
Holdings
$13,234.14
Cash
$27,942.51
Investment
$12,941.7
-$77,866.58
Profit -$122.8
Realized
-$78,159.02
Unrealized
$292.44
Dividends
$0
$27,942.51
Cash
Deposits
$119,043.23
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-0.28%
Profit
-$122.8
Win %
58%
This Week
Compared To Last Week
Gain
-0.4%
Profit
-$164.67
Win %
58%
This Month
Compared to last month
Gain
-1.35%
Profit
-$564.88
Win %
53%
This Year
Compared to last year
Gain
4.67%
Profit
$1,838.59
Win %
53%
EYPT EyePoint Pharmaceuticals Inc.
+4.49%
+$21.14 
SPTX Seaport Therapeutics, Inc.
+3.41%
+$16.8 
MIRM Mirum Pharmaceuticals Inc.
+1.17%
+$6.04 
ZLAB Zai Lab Ltd.
+0.62%
+$3.28 
LGND Ligand Pharmaceuticals Inc.
+0.4%
+$2.03 
ORIC Oric Pharmaceuticals Inc.
+0.24%
+$1.23 
APLS Apellis Pharmaceuticals Inc.
0%
$0 
KRRO Korro Bio Inc.
-6.86%
-$35.02 
CADL Candel Therapeutics Inc.
-4.74%
-$24.08 
STTK Shattuck Labs Inc.
-4.32%
-$20.58 
OLMA Olema Pharmaceuticals Inc.
-4.07%
-$20.69 
RIGL Rigel Pharmaceuticals, Inc.
-2.98%
-$15.38 
DRTS Alpha Tau Medical Ltd.
-2.69%
-$13.42 
ZBIO Zenas BioPharma, Inc.
-2.27%
-$10.96 
ACAD Acadia Pharmaceuticals Inc.
-1.83%
-$9.4 
ARVN Arvinas Inc.
-1.33%
-$6.71 
BMEA Biomea Fusion, Inc.
-0.83%
-$4.34 
NBIX Neurocrine Biosciences Inc.
-0.72%
-$3.66 
CRSP Crispr Therapeutics AG
-0.61%
-$3.27 
TVTX Travere Therapeutics Inc.
-0.41%
-$2.15 
LXRX Lexicon Pharmaceuticals, Inc.
-0.3%
-$1.56 
LENZ LENZ Therapeutics, Inc.
-0.23%
-$1.15 
KRYS Krystal Biotech Inc.
-0.22%
-$1.13 
AVBP Arrivent Biopharma Inc.
-0.07%
-$0.33 
SRPT Sarepta Therapeutics Inc.
-0.01%
+$0.1 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 2724 | Longs Won 1279/2677 47% | Profit Factor 0.58 |
| Profitability | Shorts Won 15/47 31% | Standard Deviation $903.36 |
| Average Win $83.29 | Best Trade (Mar 18) $22,985.91 | Sharpe Ratio -186.52 |
| Average Loss -$129.85 | Worst Trade (Feb 07) -$25,815.31 | Z-Score -16.53 (100%) |
| Commissions $0 | Avg. Trade Length 1m 2w 6d | Expectancy -$28.59 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 317 | 285 | 254 | 222 | 190 | 159 | 127 | 95 | 63 | 32 |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
